ERBB2 and breast cancer: PD-1 + TIL are associated with a worse overall survival in breast cancer patients [11,39], and high PD-L1 expression is seen in high TIL, high grade, hormone receptor negative, HER2 overexpressed and triple negative breast cancers (TNBCs) [40].